Skip to content
AbelZeta Pharma
Menu
Newsroom
Careers
Menu
About Us
Our Mission
Our Story
Our Leadership
Board of Directors
Scientific Advisory Board
Our Science
Our Focus
Pipeline
Clinical Trials
Publications and Presentations
Contact
Menu
About Us
Our Mission
Our Story
Our Leadership
Board of Directors
Scientific Advisory Board
Our Science
Our Focus
Pipeline
Clinical Trials
Publications and Presentations
Contact
Newsroom
Careers
Enabling Immunity
Through innovative and proprietary T-cell-based therapeutics.
READ MORE
Enabling Immunity
Through innovative and proprietary T-cell-based therapeutics.
READ MORE
AbelZeta Pharma is a global clinical-stage biopharmaceutical company focused on leveraging our R&D capabilities to discover and develop T cell-based therapeutic products to treat cancer and inflammatory & immunological diseases.
Hematological Cancers
Solid Tumors
Inflammatory & Immunological Diseases
READ MORE
Our PlatformS
CAR-T
Chimeric Antigen Receptor (CAR)-T Cell
TIL
Tumor Infiltrating Lymphocytes (TIL)
READ MORE
EMPOWERING YOUR IMMUNE SYSTEM
A Personalized Fight Against Cancer and Inflammatory & Immunological Diseases
Scroll to Top